Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-22

Clinical Trial Update: Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema [NA]

View source ↗

Summary

A clinical trial evaluating omega-3 monoglyceride-based topical prebiotics for eczema has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 Monoglyceride Topical Prebiotic (omega-3 monoglyceride)

Snippet

Sponsor: SCF Pharma | Conditions: Eczema | NA | Status: TERMINATED